Mesoblast (MESO) Interest Expenses (2015 - 2023)
Mesoblast (MESO) reported Interest Expenses of $24.4 million for Q2 2023, up 12.78% on a YoY basis from $21.6 million in Q2 2022, and up 597.57% sequentially from -$4.9 million in Q1 2023.
Mesoblast (MESO) Interest Expenses (2015 - 2023) Analysis & Trends
Mesoblast (MESO) has 9 years of Interest Expenses data on file, last reported at $24.4 million in Q2 2023.
- For the quarter ending Q2 2023, Interest Expenses rose 12.78% year-over-year to $24.4 million; the trailing twelve-month figure through Dec 2024 stood at $24.4 million (up 67.29% YoY), and the FY2025 full-year result was $23.0 million, changed 0.18% from the prior year.
- Interest Expenses rose to $24.4 million in Q2 2023, from -$4.9 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $24.4 million in Q2 2023 to a low of -$4.9 million in Q4 2022.
- A 5-year average of $2.1 million and a median of -$3.1 million in 2020 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses tumbled 554.37% in 2019 and soared 634.02% in 2020, its largest moves.
- Tracing MESO's Interest Expenses over 5 years: stood at -$2.5 million in 2019, then surged by 45.63% to -$1.4 million in 2020, then slumped by 193.99% to -$4.1 million in 2021, then slipped by 20.7% to -$4.9 million in 2022, then soared by 596.86% to $24.4 million in 2023.
- Business Quant data shows MESO's Interest Expenses at $24.4 million in Q2 2023, -$4.9 million in Q1 2023, and -$4.9 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Mesoblast | 19.81 Bn | 19.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 24.37 Mn |
| Jun 30, 2023 | 24.37 Mn |
| Mar 31, 2023 | -4.90 Mn |
| Mar 31, 2023 | -4.90 Mn |
| Dec 31, 2022 | -4.90 Mn |
| Dec 31, 2022 | -4.90 Mn |
| Sep 30, 2022 | 4.55 Mn |
| Sep 30, 2022 | 4.55 Mn |
| Jun 30, 2022 | 21.61 Mn |
| Jun 30, 2022 | 21.61 Mn |
| Mar 31, 2022 | -4.30 Mn |
| Mar 31, 2022 | -4.30 Mn |
| Dec 31, 2021 | -4.06 Mn |
| Dec 31, 2021 | -4.06 Mn |
| Sep 30, 2021 | -4.14 Mn |
| Sep 30, 2021 | -4.14 Mn |
| Jun 30, 2021 | 14.84 Mn |
| Jun 30, 2021 | 14.84 Mn |
| Mar 31, 2021 | -3.23 Mn |
| Mar 31, 2021 | -3.23 Mn |